These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8612475)

  • 1. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.
    Hall ED; McCall JM; Means ED
    Adv Pharmacol; 1994; 28():221-68. PubMed ID: 8080818
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tirilazad mesylate (Freedox)--an effective inhibitor of lipid membrane peroxidation].
    Sániová B
    Bratisl Lek Listy; 1997 Jun; 98(6):339-42. PubMed ID: 9333426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the aminosteroids in brain diseases.
    Jakobsen M
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():81-2. PubMed ID: 8899702
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapeutic potential of lazaroids (21-aminosteroids). A recent survey].
    Buttgereit F; Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1997 Oct; 122(44):1363-7. PubMed ID: 9410710
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of lipid peroxidation in central nervous system trauma and ischemia.
    Hall ED
    J Neurol Sci; 1995 Dec; 134 Suppl():79-83. PubMed ID: 8847548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid antioxidants in acute central nervous system injury.
    Hall ED
    Ann Emerg Med; 1993 Jun; 22(6):1022-7. PubMed ID: 8503522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection.
    Kavanagh RJ; Kam PC
    Br J Anaesth; 2001 Jan; 86(1):110-9. PubMed ID: 11575384
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).
    STIPAS Investigators
    Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radicals in CNS injury.
    Hall ED; Braughler JM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxygen radicals in traumatic injury: clinical implications.
    Hall ED
    J Emerg Med; 1993; 11 Suppl 1():31-6. PubMed ID: 8445200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
    Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
    J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibilities of brain protection with tirilazad after cardiac arrest.
    Sterz F; Janata K; Kürkciyan I; Müllner M; Malzer R; Schreiber W
    Semin Thromb Hemost; 1996; 22(1):105-12. PubMed ID: 8711485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of the 21-aminosteroid U74006F in acute CNS trauma and hypovolemic shock.
    Hall ED
    Acta Anaesthesiol Belg; 1987; 38(4):421-5. PubMed ID: 3327345
    [No Abstract]   [Full Text] [Related]  

  • 16. 21-Aminosteroids ("lazaroids").
    Means ED
    Adv Exp Med Biol; 1994; 366():307-12. PubMed ID: 7771261
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.
    Stroke; 1996 Sep; 27(9):1453-8. PubMed ID: 8784112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
    Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL
    Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.
    Laizure SC; Franklin LK; Kaiser DG; Williams CL; Stevens RC; Sanders PL; Miller M
    Drug Metab Dispos; 1993; 21(5):951-4. PubMed ID: 7902261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Int J Clin Pharmacol Ther; 1994 May; 32(5):223-30. PubMed ID: 7921515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.